Open Account
Demo Account
About Us
Real-time Quotes & News
Market Analysis
Economic Calendar
Daily Market Analysis
Trading Platform
Platform Overview
How To Use
Terms
All Terms
Deposit & Withdrawal
Promotion
FAQ
Contact
繁
简
EN
User Login
Open Account
Demo Account
繁
简
EN
User Login
Open Account
Demo Account
About Us
About Aspire
Features of Aspire
Real-time Quotes & News
Real-time Quotes
Real-time News
Market Analysis
Economic Calendar
Market Analysis
Trading Platform
Meta Trader 5
Platform Features
Terms
All Terms
Deposit & Withdrawal
Promotion
FAQ
Contact
About Us
Terms
Metals Market
Trading Platform
Market Analysis
Promotion
FAQ
Contact
繁
简
EN
Hong Kong-listed pharmaceutical stocks declined, with Akeso Biopharma (09926.HK) falling 24.54%, Rongchang Biopharma (09995.HK) falling over 5%, and Genscript Biotech (01548.HK) falling 3.88%.
2026-11-16
Hong Kong-listed pharmaceutical stocks declined, with Akeso Biopharma (09926.HK) falling 24.54%, Rongchang Biopharma (09995.HK) falling over 5%, and Genscript Biotech (01548.HK) falling 3.88%.
Back
Other News
2026-11-16
Tech reporter Gurman says Apple plans a foldable iPhone Duo 2 for next autumn; engineers have prototyped Face ID for the external display but development is tight and the feature may not ship. If missed, Face ID could be deferred to a third-generatio
Tech reporter Gurman says Apple plans a foldable iPhone Duo 2 for next autumn; engineers have prototyped Face ID for the external display but development is tight and the feature may not ship. If missed, Face ID could be deferred to a third-generation model in 2028. Apple is also targeting a longer telephoto lens and thinner, lighter chassis for later models.
2026-11-16
PBOC said on Nov 16, 2026 it conducted a 460 billion yuan overnight reverse repo via a fixed-rate, quantity-based tender, fully meeting primary dealers' demand.
PBOC said on Nov 16, 2026 it conducted a 460 billion yuan overnight reverse repo via a fixed-rate, quantity-based tender, fully meeting primary dealers' demand.
Chat with us
, powered by
LiveChat